ROCHELLE, Va., Feb. 13, 2019 /PRNewswire-PRWeb/ -- NDA Partners Chairman Carl Peck, MD,
Dr. Joseph is a board certified pediatrician with expertise in pediatric therapies, clinical study design, humanitarian use devices, orphan designation, and pediatric trials. In addition to her career at FDA, she has worked in private practice and in emergency medicine at Children's National Medical Center (Washington DC). She is currently a Pediatrician in the Goldberg Center for Community Pediatric Health at Children's National Medical Center and an Assistant Professor of Pediatrics at The George Washington University School of Medicine and Health Sciences (Washington DC). She is a co-investigator in the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) within The Sheikh Zayed Surgical Institute for Pediatric Surgical Innovation of Children's National Health System (Washington DC). This FDA-funded consortium is focused on accelerating the path to market for pediatric devices.
According to Dr. David Feigal, Manager of NDA Partners' Medical Device Practice, "Dr. Joseph's expertise in pediatric therapies, clinical study design, humanitarian use devices, orphan designations, and pediatric trials will greatly benefit our clients developing products for pediatric populations. We are delighted to welcome her to NDA Partners."
Dr. Joseph earned her medical degree from the State University of New York Stony Brook School of Medicine (Stony Brook, NY) and her bachelor's degree in biology from Bucknell University (Lewisburg, PA). She completed a Pediatric Internship and Residency at Children's National Medical Center and a Residency Fellowship in Public Policy from The George Washington University School of Public Health, Hirsh Program in Medicine and Health Policy.
About NDA Partners NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Contact Earle Martin, Chief Executive Officer Office: 540-738-2550 MartinEarle@ndapartners.com
SOURCE NDA Partners
Subscribe to our Free Newsletters!